The third Biomed conference will be opened by Chief Minister Hon Allan Bell on 10th December when he will welcome guests and expert speakers from throughout the world. The Conference is promoted by the Government’s Department of Economic Development, organised by Courtenay Heading and Manx Business Connection and generously sponsored by KPMG, IQE, Manx Telecom and Blatchford.
Conference delegates will hear about opportunities in the Island’s growing biomed sector, biomed innovation around the world and implications for the Island’s health and social care strategy. This means they will not only have a better understanding of the potential of this rapidly developing sector and the opportunities it presents for their own business but on a personal level learn about possible health care solutions that will affect us individually and as a community. Among those presenting this year are Dr Thishi Surendranathan, Life Sciences & Healthcare, KPMG, “The Future of Healthcare From Evolution to Revolution”; Professor Tony Whetton, Director of the Stoller Centre for Biomarker Discovery and also the Manchester Precision Medicine Institute, “Precision Medicine – Biomarkers and Companion Diagnostics”; and Phil Hastings, Linguamatics, “Text Mining of Biomedical Data - Technology, Applications and Benefits”.
In addition to speakers outlining the latest international thinking in such topics as biomarkers and diagnostics, there is local interest in discussions on sequencing of the Manx cat genome and the use of the Island’s expertise in data and software development will also feature in the programme. We are pleased that Chris Corlett, CEO of the Department of Economic Development and Dr Malcolm Couch, CEO of the Department of Health and Social Care, will be talking about the Island’s strategy towards the sector and health provision on the Island. Representatives from the already thriving Manx Biomed Sector, comprising companies who manufacture medical devices, provide services worldwide and successfully produce and market innovative solutions that are recognised internationally, will outline the nature of their business activities and why they choose to live and work on the Isle of Man. We are also pleased to invite a panel of international investors to discuss “What it Would Take for Investors to Allocate More of Their Capital into Isle of Man Based Biomed Companies” and a panel of entrepreneurs who are considering the Isle of Man as a potential location to develop their projects and establish their business.
Because of the relatively small size of the population on the Island not all the necessary specialist health services can be provided locally and so developments in areas such as telemedicine can derive particular benefit for the community. Improved access to remote diagnosis, monitoring and treatment will at the same time save taxpayers’ money and reduce the trauma of being treated away from home.
The Island’s excellent package of personal and business attractions means that innovators, investors and entrepreneurs have gravitated here generating a highly-successful and diversified economy. This existing range of companies has many beneficial consequences including the growing number of partnerships between companies and the development of new products.
Not surprisingly, the Isle of Man’s high-tech infrastructure has itself encouraged companies to grow their product ranges, using software, telecommunications and even the sophisticated manufacturing sector to leverage their products. The Conference will therefore bring together those at the forefront of biomedicine internationally with the growing, diverse and increasingly high-tech Manx business community.
You can find out more about ManxBioMed and December’s conference at www.manxbiomed.im